Jules L. Dienstag
Gastrointestinal Unit
Massachusetts General Hospital
and the Department of Medicine
Harvard Medical School
USA
Name/email consistency: high
- A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C. Dienstag, J.L., Ghany, M.G., Morgan, T.R., Di Bisceglie, A.M., Bonkovsky, H.L., Kim, H.Y., Seeff, L.B., Szabo, G., Wright, E.C., Sterling, R.K., Everson, G.T., Lindsay, K.L., Lee, W.M., Lok, A.S., Morishima, C., Stoddard, A.M., Everhart, J.E. Hepatology (2011)
- Benefits and risks of nucleoside analog therapy for hepatitis B. Dienstag, J.L. Hepatology (2009)
- Hepatitis B virus infection. Dienstag, J.L. N. Engl. J. Med. (2008)
- Cross-study analysis of the relative efficacies of oral antiviral therapies for chronic hepatitis B infection in nucleoside-naive patients. Dienstag, J.L., Wei, L.J., Xu, D., Kreter, B. Clin. Drug. Investig (2007)
- Histological outcome during long-term lamivudine therapy. Dienstag, J.L., Goldin, R.D., Heathcote, E.J., Hann, H.W., Woessner, M., Stephenson, S.L., Gardner, S., Gray, D.F., Schiff, E.R. Gastroenterology (2003)
- Durability of serologic response after lamivudine treatment of chronic hepatitis B. Dienstag, J.L., Cianciara, J., Karayalcin, S., Kowdley, K.V., Willems, B., Plisek, S., Woessner, M., Gardner, S., Schiff, E. Hepatology (2003)
- The role of liver biopsy in chronic hepatitis C. Dienstag, J.L. Hepatology (2002)
- Extended lamivudine retreatment for chronic hepatitis B: maintenance of viral suppression after discontinuation of therapy. Dienstag, J.L., Schiff, E.R., Mitchell, M., Casey, D.E., Gitlin, N., Lissoos, T., Gelb, L.D., Condreay, L., Crowther, L., Rubin, M., Brown, N. Hepatology (1999)
- Lamivudine as initial treatment for chronic hepatitis B in the United States. Dienstag, J.L., Schiff, E.R., Wright, T.L., Perrillo, R.P., Hann, H.W., Goodman, Z., Crowther, L., Condreay, L.D., Woessner, M., Rubin, M., Brown, N.A. N. Engl. J. Med. (1999)